Legal

What could have provoked Scottish company AorTech issue proceedings against a St.Jude division? Whatever it was, S.Jude will be keen to draw a line under it, given that the agreement relates to the polymer used in its Durata lead coating.

According to a press release issued by US Law firm Bernstein Liebhard LLP, FDA has received almost 17,000 adverse event reports from 2000-2011, associated with metal hip implants, such as the DePuy ASR and Pinnacle hip systems. An FDA panel has been in session for two days to discuss the situation.

The life of a medtech company is never straightforward is it? Just as Medtronic is celebrating victory in a stent graft patent case involving W.L.Gore it also emerges that it is being sued for historical royalty payments of at least $7M, which a University claims it is due because of confusing accounting practices.

The conviction of an ex-Orthofix VP of Sales for violating US anti-kickback laws is a sick-making reminder that our industry is as vulnerable as any other to the lure of filthy lucre.

Medtronic settles its shareholder class action lawsuit for $85M.

Biomet is paying out a lot of money to settle it’s bribery allegations case with US SEC and Justice Department.

St Jude agrees to a fixed forward royalty payments and to ongoing exclusive use of Kensey Nash’s Collagen in its AngioSeal device following mediated settlement.

It’s still not over for Synthes and its former executives as California sees two new lawsuits over patient deaths in the ongoing Norian bone cement story.

The Japanese way seems culturally at odds with the way many of Olympus’s overseas investors would like to see the company acting as it appoints board members from its creditor list.

3M and Porton probably didn’t exchange Christmas cards this year, and now a US judge has effectively ended the legal case in 3M’s favour that probably won’t change.

Smith & Nephew has finally settled “compliance” cases with US departments of Justice and Securities and Exchange Commission incurring penalties totalling $22.2M.

Apparently ailing 72 year old boss of PIP has now been charged with causing involuntary injury.

You say sirolimus, I say everolimus… judge says lets call the whole thing off.

Alphatec Holdings has settled with Biomet subsidiary Cross Medical over royalty dispute.